Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12944058 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis
Condition: Rhabdomyolysis
Interventions: Drug: N-Acetylcysteine;   Other: N-Acetylcystine and Non CRRT;   Other: Placebo and CRRT;   Other: Placebo and Non CRRT

Indicates status has not been verified in more than two years